Evaluation of Cervical Cytology in Women with Breast Cancer on Tamoxifen Therapy

被引：0
作者：
Urvashi Miglani
Neelam Supriya
Maninder Kaur Sood
Poonam Chhabra
机构：
[1] Deen Dayal Upadhyaya Hospital,
来源：
Indian Journal of Gynecologic Oncology | 2024年 / 22卷
关键词：
Tamoxifen; Papanicolaou smear; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[31]   Adherence to Adjuvant Tamoxifen in Mexican Young Women with Breast Cancer [J].
Martinez-Cannon, Bertha Alejandra ;
Castro-Sanchez, Andrea ;
Barragan-Carrillo, Regina ;
Pacheco, Sylvia de la Rosa ;
Platas, Alejandra ;
Fonseca, Alan ;
Vega, Yoatzin ;
Bojorquez-Velazquez, Karen ;
Bargallo-Rocha, Juan Enrique ;
Mohar, Alejandro ;
Villarreal-Garza, Cynthia .
PATIENT PREFERENCE AND ADHERENCE, 2021, 15 :1039-1049
[32]   Ovarian cysts in tamoxifen-treated women with breast cancer [J].
Inal, MM ;
Incebiyik, A ;
Sanci, M ;
Yildirim, Y ;
Polat, M ;
Pilanci, B ;
Nayki, C ;
Camuzcuoglu, H .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2005, 120 (01) :104-106
[33]   Association between tamoxifen and tooth loss in women with breast cancer [J].
Sensever, Felipe de Araujo ;
Jardim, Luisa Comerlato ;
Ferrazzo, Kivia Linhares ;
Skupien, Jovito Adiel ;
Antoniazzi, Raquel Pippi .
SUPPORTIVE CARE IN CANCER, 2022, 30 (10) :8193-8199
[34]   Effect of tamoxifen on serum cholesterol in Japanese women with breast cancer [J].
Imoto S. .
International Journal of Clinical Oncology, 1998, 3 (2) :88-92
[35]   Association between tamoxifen and tooth loss in women with breast cancer [J].
Felipe de Araujo Sensever ;
Luísa Comerlato Jardim ;
Kívia Linhares Ferrazzo ;
Jovito Adiel Skupien ;
Raquel Pippi Antoniazzi .
Supportive Care in Cancer, 2022, 30 :8193-8199
[36]   Progesterone Receptor Quantification as a Strong Prognostic Determinant in Postmenopausal Breast Cancer Women under Tamoxifen Therapy [J].
Pierre-Jean Lamy ;
Pascal Pujol ;
Simon Thezenas ;
Andrew Kramar ;
Philippe Rouanet ;
Françoise Guilleux ;
Jean Grenier .
Breast Cancer Research and Treatment, 2002, 76 :65-71
[37]   Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study [J].
Dew, JE ;
Wren, BG ;
Eden, JA .
CLIMACTERIC, 2002, 5 (02) :151-155
[38]   Tamoxifen-induced ovarian hyperstimulation during premenopausal hormonal therapy for breast cancer in Japanese women [J].
Yamazaki, Rena ;
Inokuchi, Masafumi ;
Ishikawa, Satoko ;
Myojo, Subaru ;
Iwadare, Junpei ;
Bono, Yukiko ;
Mizumoto, Yasunari ;
Nakamura, Mitsuhiro ;
Takakura, Masahiro ;
Iizuka, Takashi ;
Ohta, Tetsuo ;
Fujiwara, Hiroshi .
SPRINGERPLUS, 2015, 4 :1-5
[39]   Progesterone receptor quantification as a strong prognostic determinant in postmenopausal breast cancer women under tamoxifen therapy [J].
Lamy, PJ ;
Pujol, P ;
Thezenas, S ;
Kramar, A ;
Rouanet, P ;
Guilleux, F ;
Grenier, J .
BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 (01) :65-71
[40]   Economic evaluation of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan [J].
Kondo, M. ;
Hoshi, S-L ;
Toi, M. .
BRITISH JOURNAL OF CANCER, 2009, 100 (02) :281-290
12345